In this work, we describe protocols to investigate the role of extracellular vesicles (EVs) released by Plasmodium falciparum infected erythrocytes. In particular, we focus on the interactions of EVs with endothelial cells.
Method Article
* These authors contributed equally
In this work, we describe protocols to investigate the role of extracellular vesicles (EVs) released by Plasmodium falciparum infected erythrocytes. In particular, we focus on the interactions of EVs with endothelial cells.
Malaria is a life-threatening disease caused by Plasmodium parasites, with P. falciparum being the most prevalent on the African continent and responsible for most malaria-related deaths globally. Several factors including parasite sequestration in tissues, vascular dysfunction, and inflammatory responses influence the evolution of the disease in malaria-infected people. P. falciparum-infected red blood cells (iRBCs) release small extracellular vesicles (EVs) containing different kinds of cargo molecules that mediate pathogenesis and cellular communication between parasites and host. EVs are efficiently taken up by cells in which they modulate their function. Here we discuss strategies to address the role of EVs in parasite-host interactions. First, we describe a straightforward method for labeling and tracking EV internalization by endothelial cells, using a green cell linker dye. Second, we report a simple way to measure permeability across an endothelial cell monolayer by using a fluorescently labeled dextran. Finally, we show how to investigate the role of small non-coding RNA molecules in endothelial cell function.
According to the World Health Organization, there were 212 million new cases of malaria worldwide in 2015 and approximately 429,000 people died, mainly children under five years of age1. The mechanisms leading to severe disease, which is often associated with vascular dysfunction, remain ill-defined2. Plasmodium-iRBCs secrete small bi-lipid membrane spheres known as extracellular vesicles (EVs). It is known that these EVs are potentially relevant to the infection process and to the host immune response to infection; however, little is known about the exact function of these small vesicles during malaria infectio....
Access restricted. Please log in or start a trial to view this content.
Human RBCs were obtained from the blood of healthy donors, in accordance with the guidelines of Swissethics (swissethics.ch).
NOTE: P. falciparum parasite cultures (3D7) and EV production were previously described in Mbagwu, et al.11 Because P. falciparum is a human pathogen, consult the local regulations for handling. The cultures should be kept sterile the entire time.
1. Fluorescence Labeling of EVs
NOTE: The following procedure takes advantage of the labeling technology to stably incorporate a green fluorescent dye (PKH67) with large....
Access restricted. Please log in or start a trial to view this content.
Here, we describe protocols to investigate the interactions of EVs with host cells. The uptake of fluorescently labeled EVs is monitored by confocal microscopy (Figure 1). Endothelial cells efficiently take up EVs, however the incubation time with EVs can be optimized to track the uptake. For a better localization of EVs inside the cells, stain actin with phalloidin. Next, we use a filter membrane on top of which a monolayer of endothelial cells grows. Rhodam.......
Access restricted. Please log in or start a trial to view this content.
Several parasites, including Toxoplasma, Trypanosoma, Leishmania, and Trichomonas trigger the release of EVs by the infected host cell. Depending on the pathogens, the released EVs can modulate the host immune response or mediate cellular communication between the parasites6. Yet, there is little evidence suggesting how these small vesicles contribute to malaria disease. Here, we have described several ways to investigate the function of EVs during Plasmodium infection. For instance, the .......
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
This study was financially supported in part by the Novartis foundation for medical- and biological research (to PYM), the Gottfried and Julia Bangerter-Rhyner-Stiftung (to MW and PYM), and the research pool of the University of Fribourg (to PYM). Additional grants include the Swiss Government Excellence Scholarships for Foreign Scholars (to KAB and SM). We thank Isabelle Fellay and Solange Kharoubi Hess for technical support.
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| PKH67 Green Fluorescent Cell Linker Mini Kit | Sigma-Aldrich | MINI67-1KT | |
| Diluent C | Sigma-Aldrich | G8278 | |
| poly-L-lysine | Sigma-Aldrich | P8920 | |
| PBS | ThermoFisher - Gibco | 10010023 | |
| Phalloidin CF594 | Biotium | #00045 | |
| Hoechst 33342 | ThermoFisher | H3570 | |
| ProLong Gold Antifade Mountant | ThermoFisher | P36934 | |
| Rhodamine B isothiocyanate–Dextran | ThermoFisher | R9379-250MG | |
| Insert with PET membrane transparent Falcon for plate 24 wells | Falcon | 353095 | |
| Endothelial Cell Growth Medium MV | Promocell | C-22020 | |
| Puromycin dihydrochloride | Sigma-Aldrich | P9620-10ML | |
| MTS Cell Proliferation Colorimetric Assay Kit | Biovision | K300-500 | |
| hexadimethrine bromide | Sigma-Aldrich | 107689-10G | |
| MISSION Lenti microRNA, Human hsa-miR-451a | Sigma-Aldrich | HLMIR0583 | |
| MISSION Lenti microRNA, ath-miR416, Negative Control 1 Transduction Particles | Sigma-Aldrich | NCLMIR001 | |
| MISSION Lenti microRNA, Human | Sigma-Aldrich | NCLMIR0001 | |
| Leica TCS SP5 | Leica Microsystems | ||
| miRNeasy mini Kit | Qiagen | 217004 | |
| TaqMan MicroRNA Reverse Transcription Kit 1000 reactions | ThermoFisher | 4366597 | |
| hsa-mir-451a RT/750 PCR rxns | ThermoFisher | 001141 | |
| U6 snRNA | ThermoFisher | 001973 | |
| TaqMan Universal Master Mix II, with UNG | ThermoFisher | 4440038 | |
| StepOnePlus Real-Time PCR System | ThermoFisher | 4376600 |
Access restricted. Please log in or start a trial to view this content.
Request permission to reuse the text or figures of this JoVE article
Request Permission